Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetcall Regulatory News (NET)

Share Price Information for Netcall (NET)

Share Price is delayed by 15 minutes
Get Live Data
125.50    0.00 (0.00%)
Bid:
123.00
Ask:
128.00
Spread: 5.00 (4.065%)
Market Cap: £214.10m
NET Live PriceLast checked at - London Stock Exchange

Intraday Netcall Share Chart

Form 8 (OPD) Telephonetics plc

2 Jun 2010 16:07

RNS Number : 9703M
Telephonetics PLC
02 June 2010
 



FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER - AMENDMENT

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the party to the offer making the disclosure:

Telephonetics plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each party to the offer

Telephonetics plc

(d) Is the party to the offer making the disclosure the offeror or the offeree?

OFFEREE

(e) Date position held:

1 June 2010

(f) Has the party previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

NO

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0

0

0

(2) Derivatives (other than options):

0

0

0

0

(3) Options and agreements to purchase/sell:

0

0

0

0

 

TOTAL:

0

0

0

0

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(c) Irrevocable commitments and letters of intent

 

Details of any irrevocable commitments or letters of intent procured by the party to the offer making the disclosure or any person acting in concert with it (see Note 3 on Rule 2.11 of the Code):

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe of any person acting in concert with the party to the offer making the disclosure:

Name

Number of Telephonetics Shares

Percentage of entire existing issued share capital of Telephonetics

Mr M Neville

150,000

0.14

Mr A McKay1

19,630,994

17.99

Mr M Brooks2

10,939,255

10.02

Mr W Burgar3

19,480,994

17.85

 

1. The number of Telephonetics Shares irrevocably committed does not include options over 657,895 Telephonetics Shares granted by Anthony McKay to Cineworld Cinemas Limited which expire on or around 7 May 2012

2. The number of Telephonetics Shares irrevocably committed does not include 1,970,588 Telephonetics Shares held under his pension fund

3. The number of Telephonetics Shares irrevocably committed does not include options over 657,895 Telephonetics Shares granted by William Burgar to Cineworld Cinemas Limited which expire on or around 7 May 2012

Share Options

2005 Scheme

Name

Date of grant

Number of Ordinary Shares

Exercise Price (p)

Exercise

Period

James Ormondroyd

7 July 2005

12,275

36.0

6 July 2015

 

 

 

 

 

 

2005 Unapproved Scheme

Name

Date of grant

Number of Ordinary Shares

Exercise Price (p)

Exercise

Period

Michael Neville

7 July 2005

654,514

1.0

6 July 2015

James Ormondroyd

7 July 2005

305,555

22.0

6 July 2015

James Ormondroyd

7 July 2005

305,555

18.0

6 July 2015

 

 

 

 

 

 

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3 for each additional class of relevant security.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

2 June 2010

Contact name:

James Ormondroyd (Finance Director)

Telephone number:

+44 (0) 1442 242 242

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEEGMGGVKZKGGZM
Date   Source Headline
27th May 20268:03 amRNSHolding(s) in Company
14th May 20263:07 pmRNSDirector/PDMR Shareholding
11th May 20263:10 pmRNSNotification of major holdings
31st Mar 20267:00 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSIssue of Contingent Consideration Shares & TVR
17th Mar 20265:40 pmRNSDirector/PDMR Shareholding
4th Mar 20267:00 amRNSHalf-year Report
22nd Jan 20267:00 amRNSTrading Update and Notice of Results
7th Jan 20267:00 amRNS-R£3.0m Liberty Cloud Contract Win
17th Dec 20251:24 pmRNSResult of AGM
17th Dec 20257:00 amRNSAGM Statement
10th Dec 20257:00 amRNSAcquisition of Jadu Holdings Limited
20th Nov 20257:00 amRNSNotice of AGM and Posting of Annual Report
19th Nov 20257:00 amRNSIssue of Contingent Consideration Shares & TVR
29th Oct 20252:26 pmRNSHolding(s) in Company
8th Oct 20257:00 amRNSFinal Results for the Year Ended 30 June 2025
25th Sep 20252:49 pmRNSNotice of Results
22nd Aug 202511:48 amRNSHolding(s) in Company
4th Aug 20258:53 amRNSHolding(s) in Company
29th Jul 202512:41 pmRNSDirector/PDMR Shareholding
24th Jul 20253:34 pmRNSDirector/PDMR Shareholding
22nd Jul 20257:00 amRNSFY25 Trading Update
15th May 20257:00 amRNSExercise of Options and Total Voting Rights
15th Apr 20258:10 amRNSHolding(s) in Company
9th Apr 20253:52 pmRNSDirector/PDMR Shareholding
1st Apr 20257:00 amRNSAIM Rule 17 – Notification of shareholding
19th Mar 202511:12 amRNSHolding(s) in Company
19th Mar 202510:04 amRNSDirector/PDMR Shareholding
13th Mar 20254:44 pmRNSExercise of Options and Total Voting Rights
10th Mar 20253:56 pmRNSHolding(s) in Company
5th Mar 20257:00 amRNSHalf-year Report
29th Jan 20255:51 pmRNSExercise of Options and Total Voting Rights
28th Jan 20255:41 pmRNSHolding(s) in Company
24th Jan 202511:58 amRNSDirector/PDMR Shareholding
23rd Jan 20257:00 amRNSTrading Update
9th Jan 20257:00 amRNSDirector/PDMR Shareholding
6th Jan 20253:27 pmRNSDirector/PDMR Shareholding
31st Dec 20247:00 amRNSEstablishment of New Long-Term Incentive Plan
18th Dec 20242:05 pmRNSHolding(s) in Company
18th Dec 202410:09 amRNSHolding(s) in Company
17th Dec 202411:44 amRNSResult of AGM
17th Dec 20247:00 amRNSAGM Statement
5th Dec 20243:54 pmRNSHolding(s) in Company
4th Dec 20244:04 pmRNSHolding(s) in Company
29th Nov 20245:21 pmRNSHolding(s) in Company
18th Nov 20247:00 amRNSNotice of AGM and Posting of Annual Report
15th Nov 202412:15 pmRNSHolding(s) in Company
7th Nov 20243:39 pmRNSExercise of Options and Total Voting Rights
25th Oct 20247:00 amRNSExercise of Options, Director/PDMR Dealing and TVR
14th Oct 20242:03 pmRNSDirector/PDMR Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.